Fram Kamil M, Saleh Shawqi, Thikerallah Fidaa, Fram Farah K, Fram Rand K, Darwish Tamara, Haddad Rana, Othman Zeina
Department of Obstetrics and Gynecology, Jordan University Hospital, Amman, Jordan.
Prz Menopauzalny. 2020 Mar;19(1):25-29. doi: 10.5114/pm.2020.95332. Epub 2020 Apr 27.
Cesarean section (CS) delivery is the most common major obstetrical surgical operation carried out in and is increasing in incidence throughout the world. The major involves some risks that might include: infection, coagulation problem, loss of blood, bowel or bladder injury, abnormalities of the placenta in subsequent pregnancies.
To evaluate the clinical effectiveness of postoperative CS intra-abdominal drain insertion.
A prospective study was conducted on 245 patients in labor, at the Department of Obstetrics and Gynecology, Jordan University Hospital, between January 2017 and January 2018. Participants were divided into two groups: group I including those who had abdominal drains insertion during surgery and group II including women who had no abdominal drain inserted before closure. All patients on both groups were term pregnancies, underwent elective vs. emergency CS, and had no subcutaneous drains inserted.
Clinical and surgical parameters were comparable in both groups. Postoperative hospital stay was significantly shorter in group II, whereas specific postoperative complication rate was significantly higher in group I. Drain site infection was noted in 2 (1.6%), organ herniation in 2 (1.6%), drain avulsion in 2 (1.6%), severe pain at the site of insertion in 2 (1.6%) patients.
Routine prophylactic intra-abdominal drain insertion post CS has no benefits and therefore should be stopped.
剖宫产是全球范围内最常见的重大产科外科手术，且其发生率正在上升。主要风险可能包括：感染、凝血问题、失血、肠道或膀胱损伤、后续妊娠时胎盘异常。
评估剖宫产术后腹腔引流管置入的临床效果。
2017年1月至2018年1月期间，在约旦大学医院妇产科对245例分娩患者进行了一项前瞻性研究。参与者分为两组：第一组包括手术期间置入腹腔引流管的患者，第二组包括缝合前未置入腹腔引流管的女性。两组所有患者均为足月妊娠，接受择期或急诊剖宫产，且未置入皮下引流管。
两组的临床和手术参数具有可比性。第二组术后住院时间显著缩短，而第一组术后特定并发症发生率显著更高。2例（1.6%）出现引流部位感染，2例（1.6%）出现器官疝，2例（1.6%）出现引流管撕脱，2例（1.6%）患者在置入部位出现剧痛。
剖宫产术后常规预防性置入腹腔引流管并无益处，因此应停止。
